Revenue
98.4 thousand USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 98400 USD Source
Market value is not computed: no recent price is available.
23 filing records in this dataset, filed from 2022-04-18 to 2026-11-20. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
98.4 thousand USD
2026 Q2 · USD
-256.68%
2026 Q2 · %
-249 thousand USD
2026 Q2 · USD
16072267 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-3.12 million USD
2025-10-01 – 2026-09-30
-842 thousand USD
2025-10-01 – 2026-09-30
11 thousand USD
2022-01-01 – 2022-12-31
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-20.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 1.51 million
–
Current period
−USD 1.76 million
–
-1756096 − -1505102 = -250994 USD
-1505102 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-1756096 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 664,066
–
Current period
−USD 850,389
–
-850389 − -664066 = -186323 USD
-664066 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-850389 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value | Source evidence |
|---|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|
Cash generated by the company’s normal business operations.
| Period | Series | Value | Source evidence |
|---|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | −USD 670,614 Exact valueExact value: -670614 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 3.75 million Exact valueExact value: -3746419 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.81 million Exact valueExact value: -1806053 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 10,999 Exact valueExact value: 10999 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.82 million Calculation and evidence-1806053 − 10999 USD Exact free cash flow: -1817052 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 2.05 million Exact valueExact value: -2050664 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.62 million Exact valueExact value: -1615643 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 1.51 million Exact valueExact value: -1505102 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 664,066 Exact valueExact value: -664066 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 1.76 million Exact valueExact value: -1756096 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 850,389 Exact valueExact value: -850389 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
23 filings · 923 latest values · 923 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001850767, 1850767, ACUT, edgar:1850767
Also known as ACCUSTEM SCIENCES, INC., AccuStem Sciences Inc., AccuStem Sciences Ltd, Accustem Sciences Inc.